<DOC>
	<DOCNO>NCT02540655</DOCNO>
	<brief_summary>The purpose clinical trial study therapeutic efficacy safety Stemchymal® infusion polyglutamine spinocerebellar ataxia treatment randomize , double-blind , placebo-controlled study design . Eligible subject receive Stemchymal® intravenous infusion .</brief_summary>
	<brief_title>Efficacy Safety Study Stemchymal® Polyglutamine Spinocerebellar Ataxia</brief_title>
	<detailed_description />
	<mesh_term>Ataxia</mesh_term>
	<mesh_term>Cerebellar Ataxia</mesh_term>
	<mesh_term>Spinocerebellar Ataxias</mesh_term>
	<mesh_term>Spinocerebellar Degenerations</mesh_term>
	<criteria>1 . Subjects genotypically confirm spinocerebellar ataxia type 2 spinocerebellar ataxia type 3 . 2 . Subjects ' baseline SARA score range 8 to15 . 3 . Subjects 20 70 year age . 4 . Subjects sign informed consent . 1 . Subjects enrol kind cell therapy within six month prior screen visit . 2 . Females positive pregnancy test result . 3 . Subjects severe vital organ disease diagnose , include limited cardiac ( ex . heart failure ) , liver ( ex . acute hepatic failure chronic liver cirrhosis ) , lung ( ex . respiratory failure ) renal ( ex . hemodialysis peritoneal dialysis ) insufficiency , within six month prior screen visit . 4 . Subjects immunological disorder ( ex . Systemic lupus erythematosus ) , within six month prior screen visit . 5 . Subjects neurological disorder ( ex . Alzheimer 's disease ) , within six month prior screen visit . 6 . Subjects receive chemotherapy/radiotherapy within five year prior screen visit . 7 . Subjects history malignancy tumor . 8 . Subjects history hypersensitivity/allergy penicillin . 9 . Subjects dementia psychiatric illness , include limited disabling depression , bipolar disorder , schizophrenia . 10 . Subjects Beck Depression Inventory Second Edition ( BDIII ) score 20 point . 11 . Subjects unstable illness contraindication clinical trial accord PI 's judgment .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Stem Cells</keyword>
	<keyword>Adult Stem Cells</keyword>
	<keyword>Spinocerebellar Ataxia</keyword>
	<keyword>Steminent</keyword>
</DOC>